Association of alanine-valine manganese superoxide dismutase gene polymorphism and microheterogeneity manganese superoxide dismutase activity in breast cancer and benign breast tissue

Journal of Breast Cancer

Volumn 15, Issue 2, 2012, Pages 157-161

  Atoum, Manar ^a   Abdel Fattah, Malak ^a   Nimer, Nisreen ^a   Abdel Rahman, Saleem ^a   Abdeldayem, Sawsan A ^b  

^a HASHEMITE UNIVERSITY   (Jordan)

^b KING HUSSEIN MEDICAL CENTER   (Jordan)

Author keywords

Benign; Breast; Cancer; MnSOD; Polymorphism

Indexed keywords

ALANINE; MANGANESE SUPEROXIDE DISMUTASE; VALINE;

ADULT; ADVANCED CANCER; AGAR GEL ELECTROPHORESIS; AGED; ALLELE; ARTICLE; BENIGN TUMOR; BREAST CANCER; CANCER GROWTH; COMPETITIVE INHIBITION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION;

EID: 84865118287     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2012.15.2.157     Document Type: Article

References (29)

1. Holley AK, Dhar SK, Xu Y, St Clair DK. Manganese superoxide dismutase: beyond life and death. Amino Acids 2012;42:139-58.
2. Gago-Dominguez M, Jiang X, Castelao JE. Lipid peroxidation, oxidative stress genes and dietary factors in breast cancer protection: a hypothesis. Breast Cancer Res 2007;9:201.
3. Waris G, Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 2006;5:14.
4. Cook JA, Gius D, Wink DA, Krishna MC, Russo A, Mitchell JB. Oxidative stress, redox, and the tumor microenvironment. Semin Radiat Oncol 2004;14:259-66.
5. Wang LI, Miller DP, Sai Y, Liu G, Su L, Wain JC, et al. Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk. J Natl Cancer Inst 2001;93:1818-21.
6. Mitrunen K, Sillanpää P, Kataja V, Eskelinen M, Kosma VM, Benhamou S, et al. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis 2001;22: 827-9.
7. Millikan RC, Player J, de Cotret AR, Moorman P, Pittman G, Vannappagari V, et al. Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and whites. Breast Cancer Res 2004;6: R264-74.
8. Cai Q, Shu XO, Wen W, Cheng JR, Dai Q, Gao YT, et al. Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Breast Cancer Res 2004;6:R647-55.
9. Mukhopadhyay S, Das SK, Mukherjee S. Expression of Mn-superoxide dismutase gene in nontumorigenic and tumorigenic human mammary epithelial cells. J Biomed Biotechnol 2004;2004:195-202.
10. Negahdar M, Djalali M, Abtahi H, Sadeghi MR, Aghvami T, Javadi E, et al. Blood superoxide dismutase and catalase activities in women affected with breast cancer. Iran J Public Health 2005;34:39-43.
11. Amstad PA, Liu H, Ichimiya M, Berezesky IK, Trump BF. Manganese superoxide dismutase expression inhibits soft agar growth in JB6 clone41 mouse epidermal cells. Carcinogenesis 1997;18:479-84.
12. Lam EW, Zwacka R, Seftor EA, Nieva DR, Davidson BL, Engelhardt JF, et al. Effects of antioxidant enzyme overexpression on the invasive phenotype of hamster cheek pouch carcinoma cells. Free Radic Biol Med 1999;27:572-9.
13. Li JJ, Colburn NH, Oberley LW. Maspin gene expression in tumor suppression induced by overexpressing manganese-containing superoxide dismutase cDNA in human breast cancer cells. Carcinogenesis 1998;19: 833-9.
14. Oberley LW, Oberley TD. Role of antioxidant enzymes in the cancer phenotype. In: Massaro D, Clerch LB, editors. Oxygen, Gene Expression, and Cellular Function. New York: M. Dekker; 1997. p.279-307.
15. Zhao Y, Chaiswing L, Velez JM, Batinic-Haberle I, Colburn NH, Oberley TD, et al. p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res 2005;65:3745-50.
16. Rosenblum JS, Gilula NB, Lerner RA. On signal sequence polymorphisms and diseases of distribution. Proc Natl Acad Sci U S A 1996;93: 4471-3.
17. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun 1996;226:561-5.
18. Sutton A, Khoury H, Prip-Buus C, Cepanec C, Pessayre D, Degoul F. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 2003;13:145-57.
19. Qiu LX, Yao L, Mao C, Chen B, Zhan P, Yuan H, et al. Lack of associa tion between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects. Breast Cancer Res Treat 2010; 123:543-7.
20. Eras-Erdogan N, Akbas E, Senli H, Kul S, Colak T. Relationship between polymorphism in the manganese superoxide dismutase gene and breast cancer. Mutat Res 2009;680:7-11.
21. Atoum MF, Hourani HM, Shoter A, Al-Raheem SN, Al Muhrib TK. TNM staging and classification (familial and nonfamilial) of breast cancer in Jordanian females. Indian J Cancer 2010;47:194-8.
22. Spitz DR, Oberley LW. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 1989;179:8-18.
23. Tamimi RM, Hankinson SE, Spiegelman D, Colditz GA, Hunter DJ. Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2004;13:989-96.
24. Sun GG, Wang YD, Chen LQ, Wang SJ, Liu GL, Yu XR, et al. Novel cancer suppressor gene for esophageal cancer: manganese superoxide dismutase. Dis Esophagus. In press.
25. Park CK, Jung JH, Moon MJ, Kim YY, Kim JH, Park SH, et al. Tissue expression of manganese superoxide dismutase is a candidate prognostic marker for glioblastoma. Oncology 2009;77:178-81.
26. Baker AM, Oberley LW, Cohen MB. Expression of antioxidant enzymes in human prostatic adenocarcinoma. Prostate 1997;32:229-33.
27. Hitchler MJ, Oberley LW, Domann FE. Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells. Free Radic Biol Med 2008;45:1573-80.
28. Bag A, Bag N. Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review. Cancer Epidemiol Biomarkers Prev 2008;17:3298-305.
29. Kucukgergin C, Sanli O, Tefik T, Aydin M, Ozcan F, Seckin S. Increased risk of advanced prostate cancer associated with MnSOD Ala-9-Val gene polymorphism. Mol Biol Rep 2012;39:193-8.